Clinical Trial Update: Acetazolamide in Central Sleep Apnea Patients Using Medication for Opioid Use Disorder [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial is evaluating acetazolamide for central sleep apnea in patients using medication for opioid use disorder and is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Sleep Apnea
• Opioid Use Disorder

Drugs mentioned

• ACETAZOLAMIDE (acetazolamide)
• Diamox (acetazolamide)

Snippet

Sponsor: Sanjay R Patel | Conditions: Central Sleep Apnea Comorbid With Opioid Use | Phase 2 | Status: RECRUITING